Search Results - "KAI WIECHEN"
-
1
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
Published in The American journal of pathology (01-11-2001)“…To identify novel markers differentially expressed in ovarian cancer versus normal ovary, we hybridized microarrays with cDNAs derived from normal human…”
Get full text
Journal Article -
2
Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas
Published in The American journal of pathology (01-03-2001)“…Caveolae are plasma membrane microdomains that have been implicated in the regulation of several intracellular signaling pathways. Previous studies suggest…”
Get full text
Journal Article -
3
The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cells
Published in Oncogene (25-04-2002)“…H-rev107-1 is a growth inhibitory RAS target gene capable of suppressing anchorage independent growth in vitro and in vivo. Using a tumour tissue array with…”
Get full text
Journal Article -
4
Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer
Published in The Journal of pathology (01-01-2005)“…The identification of novel disease‐associated genes in gynaecological tumours has important implications for understanding the process of tumourigenesis and…”
Get full text
Journal Article -
5
Antisense phosphorothioate oligodeoxynucleotide down‐regulation of the insulin‐like growth factor I receptor in ovarian cancer cells
Published in International journal of cancer (12-08-1998)“…The insulin‐like growth factors (IGF‐I and IGF‐II) play a key role in cellular proliferation and are involved in cellular transformation. The expression of the…”
Get full text
Journal Article -
6
Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma: Updated results from the FAST trial
Published in Journal of clinical oncology (01-02-2019)“…Abstract only 16 Background: Physiologically, the tight junction protein CLDN18.2 is present only in the gastric mucosa. Upon malignant transformation,…”
Get full text
Journal Article -
7
c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells
Published in International journal of cancer (15-11-1995)“…Overexpression of the c-erbB-2 proto-oncogene product (p185c-erbB-2) occurs frequently in different types of human cancer and is correlated with a…”
Get more information
Journal Article -
8
Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers: Results from the FAST study
Published in Journal of clinical oncology (20-05-2017)“…Abstract only 4038 Background: Claudin 18.2 (CLDN18.2), a gastric mucosa tight junction protein, is aberrantly expressed in various cancers. In the FAST Phase…”
Get full text
Journal Article -
9
Loss of Gelsolin expression in human ovarian carcinomas
Published in European journal of cancer (1990) (01-02-2005)“…The ubiquitously expressed actin-binding protein, gelsolin, is known to play a role in the modulation of the actin network and in the regulation of cell growth…”
Get full text
Journal Article -
10
Involvement of the c‐ erb B‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells
Published in International journal of cancer (29-10-1999)Get full text
Journal Article -
11
Formalin-fixed blood clots--additional histological findings on computed tomography-guided fine-needle aspiration biopsies in comparison with core biopsies
Published in Journal of computer assisted tomography (01-05-2006)“…We investigated the diagnostic yield of histological examined formalin-fixed blood clots (FFBCs) in comparison with the established procedures of fine-needle…”
Get full text
Journal Article -
12
Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein
Published in Cancer gene therapy (01-01-1998)“…In different types of human cancer there is an overexpression of the c-erbB-2 (HER2/neu) oncogene, which is thought to be involved in tumor progression…”
Get more information
Journal Article -
13
Involvement of the c‐erbB‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells
Published in International journal of cancer (29-10-1999)“…The epidermal growth factor (EGF) induces the rapid formation of dendritic processes and the dissociation of SK‐OV‐3 ovarian cancer cells. The SK‐OV‐3 cell…”
Get full text
Journal Article -
14
The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFN[gamma]-induced cell death in human ovarian carcinoma cells
Published in Oncogene (25-04-2002)“…H-rev107-1 is a growth inhibitory RAS target gene capable of suppressing anchorage independent growth in vitro and in vivo. Using a tumour tissue array with…”
Get full text
Journal Article -
15
The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells
Published in Oncogene (25-04-2002)“…H-rev107-1 is a growth inhibitory RAS target gene capable of suppressing anchorage independent growth in vitro and in vivo. Using a tumour tissue array with…”
Get full text
Journal Article -
16
-
17
-
18
Isoelectric focusing of amniotic fluid alpha-fetoprotein to improve diagnosis of neural tube defects
Published in The Lancet (British edition) (16-03-1991)Get more information
Journal Article -
19
Isoelectric focusing pattern of human amniotic fluid alpha-fetoprotein
Published in Prenatal diagnosis (01-07-1991)“…Isoelectric focusing (IEF) of amniotic fluid alpha-fetoprotein (AFP) in thin-layer polyacrylamide gels containing 8 M urea followed by immunoblotting reveals…”
Get more information
Journal Article